Prevalence and risk factors of Hepatitis C virus in Phetchabun
Article Sidebar
Main Article Content
Abstract
Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma. There is a high prevalence of HCV in Phetchabun province, thus, this study aims to study the prevalence and factors associated with HCV infection in the province. Sampling of 4918 individuals ages 35 years and over who were residing in Phetchabun. A cross-sectional study was carried out by testing for HCV infection in the laboratory with a strip test and collecting the risk factors of the group by using a questionnaire. The pattern of HCV infection was analyzed according to geographic region and risk factors. Percentage calculation and Logistic Regression data were analyzed. The results showed that the seroprevalence of HCV in Phetchabun was 6.4%. Socioeconomic and demographic factors including male gender, education, temporary employee was associated with HCV infection. The important risk factors associated with HCV infection included a history of injection drug use [OR=10.07(95%CI 5.16-19.64), p<0.001, and tattoo [OR=2.12 (95%CI 1.56-2.86, p<0.001]. Prevalence of HCV infection was higher among people living in northern area of the provence than those in the southern area. This information may be necessary for public health surveillance and prevention of hepatitis C infection. Prevention should target those who at risk and involve providing education, reducing risk by counseling, screening HCV, care and treatment for chronic HCV patients.
Article Details
ข้อลิขสิทธิ์วารสาร
บทความหรือข้อคิดเห็นใดๆ ที่ปรากฏในวารสารวิชาการป้องกันควบคุมโรค สคร. 2 พิษณุโลก เป็นวรรณกรรมของผู้เขียน กองบรรณาธิการวิชาการ และ สำนักงานป้องกันควบคุมโรคที่ 2 จังหวัดพิษณุโลกไม่จำเป็นต้องเห็นพ้องด้วยทั้งหมดหรือร่วมรับผืิดชอบใดๆ
References
2017 [cited 2020 Apr 19].
2. Trad D, Bibani N, Sabbah M, Elloumi H, Gargouri D, Ouakaa A, et al. Known, new and emerging risk factors of hepatocellular carcinoma (review). Presse Med 2017; 46(11): 1000-1007.
3. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22(34): 7824–40.
4. Wasitthankasem R, Posuwan N, Vichaiwattana P, Theamboonlers A, Klinfueng S, Vuthitanachot V, et al. Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey. PLoS ONE 2016; 11(2): e0149362
5. Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, et al. Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence. PLoS ONE 2017; 12(5): e0177022.
6. Tavoschi L, Mason L, Petriti U, Bunge E, Veldhuijzen I, Duffell E. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area. J Hosp Infect 2019; 102(4):359–68.
7. Tohme RA, Holmberg SD. Transmission of Hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis 2012 ;54(8):1167–78.
8. Yang S, Wang D, Zhang Y, Yu C, Ren J, Xu K, et al. Transmission of hepatitis B and C virus infection through body piercing: a systematic Review and meta-analysis. Medicine (Baltimore) 2015;94(47):e1893.
9. Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, et al. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study. J Int AIDS Soc 2016;19(1)
10. Phylogeography, Risk factors and genetic history of hepatitis C virus in gabon, Central Africa. PLOS ONE 2012;7(8):e42002.
11. Umutesi J, Liu CY, Penkunas MJ, Makuza JD, Ntihabose CK, Umuraza S, et al. Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population. BMJ Open 2019 ;9(7).
12. Tattooing Significantly Increases the Risk of Contracting Hep C. POZ 2010 .
13. Sawanpanyalert P, Boonmar S, Maeda T, Matsuura Y, Miyamura T. Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic areain Thailand. J7 Epidemiol Community Health 1996.
14. Triantos C, Konstantakis C, Tselekouni P, Kalafateli M, Aggeletopoulou I, Manolakopoulos S. Epidemiology of hepatitis C in Greece. World J Gastroenterol 2016; 22(36): 8094–102.
15. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis 2010; 14(11): e928–40.
16. Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002 ; 24(1): 31–5.
17. Weitzel T, Rodríguez F, Noriega LM, Marcotti A, Duran L, Palavecino C, et al. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey. PLOS ONE 2020; 15(1): e0227776.
18. Fill MA, Sizemore LA, Rickles M, Cooper KC, Buecker CM, Mullins HL, et al. Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence population. Epidemiol Infect. 2018 ;146(4):508–14.
19. Luksamijarulkul P, Piroonamornpun P, Triamchaisri SK. Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand. Hepat Mon 2011;11(4):273–7.
20. Comas LG, Gavín MO, Moreno JCS, Blázquez BR, Rodríguez AG, Mochales JA, et al. Prevalence of hepatitis C antibodies in the population aged 16–80 years in the Community of Madrid 2008–2009. J Med Virol 2015;87(10):1697–701.
21. ประวัติหล่มเก่า - ไทหล่มแท้แท้แน๊ว [Internet]. 1982 [cited 2020 May 20]. Available from: https://sites.google.com/site/thailomkao/prawati-hlmkea
22. วิศัลย์ โฆษิตานนท์. ไทหล่มและลาวพุงขาว [Internet]. 2014 Available from: https://wisonk.wordpress.com/2014/11/15/
23. Belaunzarán-Zamudio PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, Ahmed S, Beyrer C. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS ONE 2017; 12(6).
24. Tanwandee T, Piratvisuth T, Phornphutkul K, Mairiang P, Permpikul P, Poovorawan Y. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study. J Med Assoc Thail Chotmaihet Thangphaet 2006; 89(Suppl).
